(Q37889776)

24 August 2017

1 reference

title

Hairy cell leukaemia: biological and clinical overview from immunogenetic insights (English)

1 reference

24 August 2017

1 reference

1

1 reference

24 August 2017

publication date

2 November 2010

1 reference

24 August 2017

published in

Hematological Oncology

1 reference

24 August 2017

volume

29

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

55-66

1 reference

Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1)

24 August 2017

cites work

1 reference

Immunotoxins in the treatment of refractory hairy cell leukemia

21 January 2018

1 reference

The heterogeneity of leukemic reticuloendotheliosis, "hairy cell leukemia". Evidence for its monocytic origin

21 January 2018

1 reference

Fc Receptor Bearing 'Hairy Cells' of Leukaemic Reticuloendotheliosis Bind Soluble Antigen-Antibody Complexes and Adhere to Immobilized Complexes, but Fail to Mediate Antibody Dependent Cellular Cytotoxicity

21 January 2018

1 reference

Surface immunoglobulins on hairy cells of 55 patients with hairy cell leukemia

21 January 2018

1 reference

Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia

21 January 2018

1 reference

Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptors

21 January 2018

1 reference

Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells.

21 January 2018

1 reference

Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells

21 January 2018

1 reference

Defining origins of malignant B cells: a new circulating normal human IgM(+)D(+) B-cell subset lacking CD27 expression and displaying somatically mutated IGHV genes as a relevant memory population.

21 January 2018

1 reference

B lymphocytes from early vertebrates have potent phagocytic and microbicidal abilities.

21 January 2018

1 reference

Evolving concepts in the pathogenesis of hairy-cell leukaemia

21 January 2018

1 reference

The biology of hairy-cell leukaemia

21 January 2018

1 reference

The role of autocrine FGF-2 in the distinctive bone marrow fibrosis of hairy-cell leukemia (HCL).

21 January 2018

1 reference

The pathophysiology of the hairy cell

21 January 2018

1 reference

TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia

21 January 2018

1 reference

High density genome-wide DNA profiling reveals a remarkably stable profile in hairy cell leukaemia.

21 January 2018

1 reference

FOP-FGFR1 tyrosine kinase, the product of a t(6;8) translocation, induces a fatal myeloproliferative disease in mice

21 January 2018

1 reference

High-resolution analysis of chromosome rearrangements on 8p in breast, colon and pancreatic cancer reveals a complex pattern of loss, gain and translocation

21 January 2018

1 reference

Genomic disorders: molecular mechanisms for rearrangements and conveyed phenotypes

21 January 2018

1 reference

Alpha interferon for induction of remission in hairy-cell leukemia

21 January 2018

1 reference

Characterization of T-cell repertoire in hairy cell leukemia patients before and after recombinant immunotoxin BL22 therapy

21 January 2018

1 reference

Effector and regulatory B cells: modulators of CD4+ T cell immunity

21 January 2018

1 reference

Lymphocyte development: overview

21 January 2018

1 reference

The development of B cells and the B-cell repertoire in the microenvironment of the germinal center

21 January 2018

1 reference

The occurrence and significance of V gene mutations in B cell-derived human malignancy

21 January 2018

1 reference

Molecular mechanism of class switch recombination: linkage with somatic hypermutation

21 January 2018

1 reference

Receptor revision plays no major role in shaping the receptor repertoire of human memory B cells after the onset of somatic hypermutation.

21 January 2018

1 reference

Extrafollicular antibody responses

21 January 2018

1 reference

VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome.

21 January 2018

1 reference

Hairy cell leukemia: at the crossroad of somatic mutation and isotype switch

21 January 2018

1 reference

Developmentally restricted immunoglobulin heavy chain variable region gene expressed at high frequency in chronic lymphocytic leukemia

21 January 2018

1 reference

Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis.

21 January 2018

1 reference

Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins

21 January 2018

1 reference

Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3.

21 January 2018

1 reference

Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia

21 January 2018

1 reference

Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations.

21 January 2018

1 reference

The normal IGHV1-69-derived B-cell repertoire contains stereotypic patterns characteristic of unmutated CLL.

21 January 2018

1 reference

Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior

21 January 2018

1 reference

Transcription enhances AID-mediated cytidine deamination by exposing single-stranded DNA on the nontemplate strand

21 January 2018

1 reference

Isolation, tissue distribution, and chromosomal localization of the human activation-induced cytidine deaminase (AID) gene

21 January 2018

1 reference

Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas

21 January 2018

1 reference

A coding-independent function of gene and pseudogene mRNAs regulates tumour biology

21 January 2018

1 reference

Do CLL B cells correspond to naive or memory B-lymphocytes? Evidence for an active Ig switch unrelated to phenotype expression and Ig mutational pattern in B-CLL cells.

21 January 2018

1 reference

Towards the pharmacotherapy of hairy cell leukaemia

21 January 2018

1 reference

Response of hairy cells to IFN-alpha involves induction of apoptosis through autocrine TNF-alpha and protection by adhesion

21 January 2018

1 reference

Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis

21 January 2018

1 reference

Rituximab, a chimaeric anti-CD20 monoclonal antibody, in the treatment of hairy cell leukaemia

21 January 2018

1 reference

Eradication of minimal residual disease in hairy cell leukemia

21 January 2018

1 reference

Rituximab in relapsed or refractory hairy cell leukemia

21 January 2018

1 reference

Complete molecular remission induced by concomitant cladribine--rituximab treatment in a case of multi-resistant hairy cell leukemia

21 January 2018

1 reference

Extended follow-up of patients with hairy cell leukemia after treatment with cladribine

21 January 2018

1 reference

Recombinant immunotoxins for the treatment of chemoresistant hematologic malignancies.

21 January 2018

1 reference

Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemia

21 January 2018

1 reference

Combination therapies to improve the long-term outcome in hairy cell leukemia.

21 January 2018

1 reference

2-Chlorodeoxyadenosine: a newer purine analog active in the treatment of indolent lymphoid malignancies

21 January 2018

1 reference

Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia.

21 January 2018

1 reference

Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years

21 January 2018

1 reference

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

21 January 2018

1 reference

Chronic lymphocytic leukemia: revelations from the B-cell receptor.

21 January 2018

1 reference

Genomic aberrations and survival in chronic lymphocytic leukemia

21 January 2018

1 reference

The effect of p53 dysfunction on purine analogue cytotoxicity in chronic lymphocytic leukaemia.

21 January 2018

1 reference

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

21 January 2018

1 reference

Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up

21 January 2018

1 reference

The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness.

21 January 2018

1 reference

Binet's staging system and VH genes are independent but complementary prognostic indicators in chronic lymphocytic leukemia

21 January 2018

1 reference

VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy

21 January 2018

1 reference

BL22 and lymphoid malignancies

21 January 2018

1 reference

The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia

21 January 2018

1 reference

Tumor cells of hairy cell leukemia express multiple clonally related immunoglobulin isotypes via RNA splicing

21 January 2018

1 reference

VH gene expression in hairy cell leukaemia

21 January 2018

1 reference

Selective influences in the expressed immunoglobulin heavy and light chain gene repertoire in hairy cell leukemia

21 January 2018

1 reference

Phagocytic Potential of Hairy Cells

21 January 2018

1 reference

7 January 2021

Phagocytic capacity of hairy cells from seventeen patients

1 reference

7 January 2021

Expression of an accessory cell phenotype by hairy cells during lymphocyte colony formation in agar culture

1 reference

7 January 2021

Hairy cell leukemia cells express CD1a antigen

1 reference

7 January 2021

Hairy Cell Leukemia: Proliferation of a Cell with Phagocytic and B-Lymphocyte Properties

1 reference

7 January 2021

Surface immunoglobulin, lectin-induced cap formation, and phagocytic function in five patients with the leukemic phase of hairy cell leukemia

1 reference

7 January 2021

V(H) gene analysis of hairy cell leukemia reveals a homogeneous mutation status and suggests its marginal zone B-cell origin

1 reference

7 January 2021

Phenotype and genotype of interfollicular large B cells, a subpopulation of lymphocytes often with dendritic morphology

1 reference

7 January 2021

Phenotypic changes of phytohaemagglutinin-stimulated hairy cells

1 reference

7 January 2021

Constitutive production of tumor necrosis factor-alpha in hairy cell leukemia: possible role in the pathogenesis of the cytopenia(s) and effect of treatment with interferon-alpha

1 reference

7 January 2021

Neoteny in lymphocytes: Rag1 and Rag2 expression in germinal center B cells

1 reference

7 January 2021

Re-expression of RAG-1 and RAG-2 genes and evidence for secondary rearrangements in human germinal center B lymphocytes

1 reference

7 January 2021

Somatic hypermutation and VH gene usage in hairy cell leukaemia

1 reference

7 January 2021

Heterogeneous somatic hypermutation status confounds the cell of origin in hairy cell leukemia

1 reference

7 January 2021

Further Evidence for the Lymphocytic Nature of Leukaemic Reticuloendotheliosis (Hairy-Cell Leukaemia)

1 reference

7 January 2021

Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study

1 reference

7 January 2021

Complete remission in hairy cell leukaemia achieved with pentostatin

1 reference

7 January 2021

Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine

1 reference

7 January 2021

Peripheral blood and bone marrow changes following 2'-deoxycoformycin therapy in hairy cell leukemia. Results of 200 weeks' follow-up

1 reference

7 January 2021

Immunosuppressive effects of pentostatin

1 reference

7 January 2021

Immunotoxins for targeted cancer therapy

1 reference

7 January 2021

Phase I trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with B-cell malignancies

1 reference

7 January 2021

1 reference

7 January 2021

A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease

1 reference

7 January 2021

Identifiers

DOI

10.1002/HON.975

1 reference

24 August 2017

1 reference